Sales 17% y-o-y but -4% vs. ABGSCe
Expect negative estimate revisions on higher costs
Share is trading at 21x ‘23e EV/EBIT on unrevised ests.
Q2 results
Sales SEK 120m (-4.1% vs ABGSC 125m), EBITDA SEK 15m (-29.1% vs ABGSC 21m), EBIT SEK 0.4m (-95.0% vs ABGSC 8m). While growth was good at 17% y-o-y, sales came in -4% vs. ABGSC. This, in combination with slightly higher costs than expected, led to softer profits than our forecast.
LÄS MER